Farther Finance Advisors Boosts Johnson & Johnson Holdings

Investment firm increases stake in pharmaceutical giant by 28.4% in Q4 2025

Apr. 18, 2026 at 7:59am

Got story updates? Submit your updates here. ›

An extreme close-up of the inner workings of a complex financial mechanism, representing the institutional investment in a major healthcare company.Farther Finance Advisors' increased investment in Johnson & Johnson reflects the healthcare giant's enduring institutional appeal.New Brunswick Today

Farther Finance Advisors LLC, an institutional investor, increased its holdings in Johnson & Johnson (NYSE: JNJ) by 28.4% during the fourth quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 106,454 shares of the healthcare company's stock, valued at $22,031,000 at the end of the quarter.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. Institutional investors closely monitor changes in ownership of major blue-chip stocks like JNJ, as it can signal broader market trends and investor sentiment.

The details

Farther Finance Advisors acquired an additional 23,522 shares of Johnson & Johnson during the fourth quarter, bringing its total position to 106,454 shares. This represents a 28.4% increase in the firm's holdings of the stock. Several other hedge funds and institutional investors also made changes to their JNJ positions during the quarter, with some adding to their stakes and others reducing exposure.

  • Farther Finance Advisors increased its Johnson & Johnson holdings in the fourth quarter of 2025.
  • The 13F filing disclosing the change in ownership was published on April 18, 2026.

The players

Farther Finance Advisors LLC

An institutional investment firm that manages a portfolio of stocks, bonds, and other financial assets on behalf of clients.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.

Got photos? Submit your photos here. ›

The takeaway

The increase in Farther Finance Advisors' Johnson & Johnson holdings suggests the firm sees continued growth potential in the healthcare giant's diversified business model and product pipeline. As a bellwether stock, changes in JNJ ownership can provide insights into broader market trends and investor sentiment.